NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 22 of 22 results found.

Activity Company Description Location
Company Aceragen Inc. Activity: Research and Development Research and Development Company Description Aceragen is a drug development company advancing a late-stage therapy for Farber disease Location Research Triangle Park
Company Adrenas Therapeutics Inc. Activity: Research and Development Research and Development Company Description Adrenas Therapeutics, a Bridge Bio subsidiary, is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. Location Raleigh
Company AMO Pharma Ltd. Activity: Research and Development Research and Development Company Description AMO Pharma is developing new treatments for serious and debilitating diseases including rare genetic disorders. Location Durham
Company Artiam Bio Inc. Activity: Research and Development Research and Development Company Description Artiam Bio is targeting the endocannabinoid system to treat diseases using pharmacology and medicinal chemistry approaches. Artiam Bio is initially focused on non-alcoholic and alcoholic liver diseases, Prader Willi syndrome and cannabis use disorder. Location Morrisville
Company AskBio Activity: Research and Development Research and Development Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. Location Research Triangle Park
Company Baebies Inc. Activity: Production and Manufacturing Production and Manufacturing Company Description Baebies develops and commercializes products and services based on digital microfluidics and other technology that ensure early disease detection and comprehensive diagnosis for children. Location Durham
Company bluebird bio Inc. Activity: Production and Manufacturing Production and Manufacturing Company Description bluebird bio develops gene therapies and cancer immunotherapies for the treatment of genetic diseases and cancer. At its Durham site, bluebird produces lentiviral vectors for the company's gene and cell therapies. Location Durham
Company Chiesi USA Inc. Activity: Research and Development Research and Development Company Description Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of rare disease, respiratory, cardiovascular, neonatology and cystic fibrosis. Location Cary
Company Collaborations Pharmaceuticals Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description Collaborations Pharmaceuticals develops drugs for rare and neglected diseases using machine learning software, providing preclinical and clinical expertise to rare disease foundations, academic scientists and companies developing clinical candidates. Location Raleigh
Company Couragen Biopharmaceutics LLC Activity: Research and Development Research and Development Company Description Couragen Biopharmaceutics develops gene and protein therapy products for preclinical and clinical use for the treatment of genetic and chronic diseases. Couragen also provides custom adeno-associated virus vectors as a tool for laboratory research. Location Chapel Hill
Company Enzerna Biosciences Inc. Activity: Research and Development Research and Development Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. Location Chapel Hill
Company Enzyvant Inc. Activity: Research and Development Research and Development Company Description Enzyvant develops therapeutics for treatment of rare diseases. Their focuses are RVT-802, an investigational tissue-based therapy for immune deficiency resulting from DiGeorge Anomaly, and RVT-801, an enzyme replacement therapy to treat Farber disease. Location Durham
Company Genencine Therapeutics LLC Activity: Research and Development Research and Development Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. Location Durham
Company Jaguar Gene Therapy LLC Activity: Research and Development Research and Development Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. Location Cary
Company Juno Metabolomics LLC Activity: Production and Manufacturing Production and Manufacturing Company Description Juno Metabolomics is developing next-generation metabolomics for precision medicine. Location Chapel Hill
Company MitoRainbow Therapeutics Inc. Activity: Research and Development Research and Development Company Description MitoRainbow is developing treatments for TK2 deficiency, a mitochondrial disease that manifests as severe myopathy. Location Cary
Company ML Bio Solutions Inc. Activity: Research and Development Research and Development Company Description ML Bio Solutions is developing an oral treatment for patients with limb girdle muscular dystrophy 2i. Location Charlotte
Company NeuroGT Inc. Activity: Research and Development Research and Development Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. Location Durham
Company Novartis Gene Therapies Activity: Production and Manufacturing Production and Manufacturing Company Description Novartis Gene Therapies develops and commercializes gene therapy products for neurological genetic diseases. The Durham site is Novartis Gene Therapies' manufacturing operations. Location Durham
Company QOL Medical LLC Activity: Sales and Operations Sales and Operations Company Description QOL Medical commercializes existing and complementary new orphan products for metabolic disease and pediatric gastroenterology. Location Raleigh
Company Rescindo Therapeutics Inc. Activity: Research and Development Research and Development Company Description Rescindo Therapeutics, Inc. is a drug discovery & development company focused on rare genetic diseases, especially those affecting children. Location Cary
Company Tellus Therapeutics Inc. Activity: Research and Development Research and Development Company Description Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Location Hillsborough